GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » 22nd Century Group Inc (NAS:XXII) » Definitions » Short Interest

22nd Century Group (22nd Century Group) Short Interest


View and export this data going back to 2011. Start your Free Trial

What is 22nd Century Group Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of 22nd Century Group's Short Interest

For the Tobacco subindustry, 22nd Century Group's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


22nd Century Group's Short Interest Distribution in the Tobacco Products Industry

For the Tobacco Products industry and Consumer Defensive sector, 22nd Century Group's Short Interest distribution charts can be found below:

* The bar in red indicates where 22nd Century Group's Short Interest falls into.



22nd Century Group (22nd Century Group) Business Description

Traded in Other Exchanges
N/A
Address
500 Seneca Street, Suite 507, Buffalo, NY, USA, 14204
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has two operating segments; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain 95% less nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM, and The hemp/cannabis segment is engaged in providing hemp-derived cannabinoid ingredients and API, as well as a CDMO to the consumer goods industry. It derives a majority of its revenue from the tobacco segment.
Executives
Andrew Arno director C/O MERRIMAN CURHAN FORD GROUP, INC., 600 CALIFORNIA STREET, 9TH FLOOR, SAN FRANCISCO CA 94108
James A Mish director, officer: Chief Executive Officer 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
John Franzino officer: Chief Administrative Officer 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Peter Ferola officer: Chief Legal Officer BIOTELEMETRY, INC., 1000 CEDAR HOLLOW ROAD, #102, MALVERN PA 19355
John J Miller officer: President, Tobacco 500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Lucille S Salhany director C/O HEWLETT-PACKARD CO, 3000 HANOVER STREET, PALO ALTO CA 94304
Michael Zercher officer: Chief Operating Officer 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Robert Hugh Kinsman officer: Chief Financial Officer 500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Clifford B Fleet director 6601 WEST BROAD STREET, RICHMOND VA 23230
Richard F Fitzgerald officer: Chief Financial Officer C/O TECHPRECISION CORPORATION, ONE BELLA DRIVE, WESTMINSTER MA 01473
Anthony L. Johnson director C/O 22ND CENTURY GROUP, INC., 500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Richard M. Sanders director 1119 PIEDRA RONDO, SANTA FE NM 87501
Roger D O'brien director C/O 22ND CENTURY GROUP, INC., 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Michael Koganov director 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Nora B Sullivan director C/O RAND CAPITAL CORP, 2200 RAND BLDG, BUFFALO NY 14203